Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

$SKIN
Medical/Dental Instruments
Health Care
Get the next $SKIN alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SAUNDERS BRENT L

(Last) (First) (Middle)
C/O THE BEAUTY HEALTH COMPANY
2165 SPRING STREET

(Street)
LONG BEACH CA 90806

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) X Other (specify below)
Chairman
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/12/2024 P 40,450 A $1.08 5,921,769 D
Class A Common Stock 1,681,771 I By Triplet(1)
Class A Common Stock 1,121,180 I By Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents securities held by Triplet Enterprises III, LLC ("Triplet"). The reporting person is the managing member of Triplet and may be deemed to beneficially own the securities held by Triplet, but disclaims beneficial ownership of such securities except to any pecuniary interest he may have therein.
2. Represents securities held by the Saunders Family Trust ("Trust"). The reporting person has voting and dispositive control over these securities and thus the reporting person may be deemed to beneficially own the securities held by Trust, but disclaims beneficial ownership of such securities except to any pecuniary interest he may have therein.
Remarks:
/s/ Brenton L. Saunders 08/13/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $SKIN alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SKIN

DatePrice TargetRatingAnalyst
11/15/2023$11.00 → $1.50Buy → Hold
Jefferies
11/14/2023$10.00 → $2.50Buy → Hold
Canaccord Genuity
11/14/2023Neutral → Underweight
JP Morgan
11/14/2023$12.00 → $2.00Overweight → Underweight
Piper Sandler
11/14/2023$9.00 → $2.50Outperform → Market Perform
TD Cowen
11/14/2023Buy → Hold
The Benchmark Company
11/14/2023Mkt Perform → Underperform
Raymond James
11/14/2023Outperform → Mkt Perform
William Blair
More analyst ratings

$SKIN
Press Releases

Fastest customizable press release news feed in the world

See more
  • BeautyHealth Appoints Stephen J. Fanning to Board of Directors

    Medical Aesthetics Veteran Brings Extensive Industry Knowledge and Proven Success in Driving Global Growth The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of medical aesthetics veteran, Stephen J. Fanning, to its Board of Directors, effective as of December 12, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241217181688/en/Stephen J. Fanning, Director, The Beauty Health Company (Photo: Business Wire) Mr. Fanning brings decades of global medical aesthetics experience, including serving as Hydrafacial's Chairman of the Board from 2016 to 2020, prior to the Compan

    $SKIN
    Medical/Dental Instruments
    Health Care
  • BeautyHealth Releases 2024 Skintuition Report

    Leverages data and insights from unmatched device footprint and provider community to reveal the trends that defined 2024 and those poised to influence 2025 The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, has unveiled its 2024 Skintuition Report, an annual publication that highlights BeautyHealth's collective expertise. The report draws on the science behind its innovative treatments and insights from treatment rooms worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211014299/en/BeautyHealth Releases 2024 Skintuition Report (Graphic: Business Wire) "In 2024, the line between the beauty sh

    $SKIN
    Medical/Dental Instruments
    Health Care
  • BeautyHealth Reports Third Quarter 2024 Financial Results

    Delivers third quarter net sales of $78.8 million; Delivers improved profitability as strategic initiatives start to take hold Successfully launches Hydralock HA Booster The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2024 ("Q3 2024"). "We delivered revenue above the midpoint of our guidance, with growth in consumables sales driven by sustained demand for Hydrafacial treatments and the successful launch of the Hydralock HA Booster," said BeautyHealth Chief Executive Officer Marla Beck. "Our ability to expand gross margins and achieve adjusted EBITDA profitability

    $SKIN
    Medical/Dental Instruments
    Health Care

$SKIN
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$SKIN
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$SKIN
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$SKIN
SEC Filings

See more

$SKIN
Leadership Updates

Live Leadership Updates

See more
  • The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t

    $SKIN
    Medical/Dental Instruments
    Health Care
  • BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately. Ms. Lewis will report to BeautyHealth's President and Chief Executive Officer, Marla Beck. "Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company," said Marla Beck, BeautyHealth President and Chief Executive Officer. "The Board of Directors and I are confident that her deep industry experience across global supply chain and operations will play a critical role in advancing our strategic

    $SKIN
    Medical/Dental Instruments
    Health Care
  • BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company's permanent President and Chief Executive Officer. Ms. Beck has been Interim CEO since November 20, 2023, in addition to serving on the Company's Board of Directors, which she will continue to do going forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312423257/en/SKIN) (Photo: Business Wire)">Marla Beck, President and Chief Executive Officer, The Beauty Health Company (NASDAQ:SKIN) (Photo: Business Wire) "Over the past few months, the Board has undertaken

    $SKIN
    Medical/Dental Instruments
    Health Care

$SKIN
Financials

Live finance-specific insights

See more
  • BeautyHealth Reports Third Quarter 2024 Financial Results

    Delivers third quarter net sales of $78.8 million; Delivers improved profitability as strategic initiatives start to take hold Successfully launches Hydralock HA Booster The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2024 ("Q3 2024"). "We delivered revenue above the midpoint of our guidance, with growth in consumables sales driven by sustained demand for Hydrafacial treatments and the successful launch of the Hydralock HA Booster," said BeautyHealth Chief Executive Officer Marla Beck. "Our ability to expand gross margins and achieve adjusted EBITDA profitability

    $SKIN
    Medical/Dental Instruments
    Health Care
  • BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report third quarter 2024 financial results after market close on Tuesday, November 12, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the public through a varie

    $SKIN
    Medical/Dental Instruments
    Health Care
  • BeautyHealth Reports Second Quarter 2024 Financial Results

    Delivers second quarter net sales of $90.6 million; Year-over-year operating expense improvement of nearly $18 million or 22%; Revises full year financial guidance The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2024 ("Q2 2024"). For the quarter, net sales of $90.6 million decreased (22.9)% relative to the same period in 2023. Second quarter results reflect lower equipment sales partially offset by steady growth in consumables net sales. "Our second quarter results reflect continued demand for Hydrafacial treatments with growth in consumables sales, offset by a slowe

    $SKIN
    Medical/Dental Instruments
    Health Care

$SKIN
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more